Healthcare

Bioprocessing

The healthcare industry is seeing an increased emphasis on emerging therapeutic modalities such as cell and gene therapy. But the ecosystem required to support these sectors is still young and fragmented. 

Working with businesses across this developing sector, we support the growth of cutting-edge companies that are producing and distributing vaccines, therapeutics, antibiotics, diagnostics and more. With extensive experience in biopharma and adjacent areas like pharma services, our investment professionals partner with companies focused on large molecule therapeutics—a growing and vital component of biopharma.

We believe there is substantial opportunity to invest in the large molecule ecosystem to help accelerate the development, manufacturing and distribution of lifesaving therapeutics.

Megan Preiner Megan Preiner Managing Director
Forward Through Uncertainty: What Biopharma Leaders Are Saying About the FDA, R&D Investment
Insights
Forward Through Uncertainty: What Biopharma Leaders Are Saying About the FDA, R&D Investment 

Key Takeaways Recent FDA changes have generated uncertainty across the biopharma sector, with questions mounting around approval timelines, shifting trial expectations, and regulatory consistency. In May and June 2025, THL surveyed 100 biopharma decision-makers—spanning early-stage biotechs to top 50 pharma companies—to better understand how today’s regulatory and market dynamics are influencing R&D investment. Most respondents plan to maintain

Healthcare (HC)
From One to Twenty: How CSafe Became a Leader in the Pharma Cold Chain
Insights
From One to Twenty: How CSafe Became a Leader in the Pharma Cold Chain 

In the world of pharmaceutical logistics, maintaining the precise temperature of biologically based therapies like the Covid vaccine is mission critical. Even minor temperature fluctuations can compromise the efficacy of life-saving drugs. CSafe, a leading provider of cold chain shipping solutions, ensures that pharmaceutical products reach their destination without deviation from required temperature set points. Its

Healthcare (HC)
2023 Healthcare Trends and Our Outlook for 2024
Insights
2023 Healthcare Trends and Our Outlook for 2024 

Operational Challenges, Patent Cliffs & Biotech Funding Slowdown, and Generative AI Define 2023; Encouraging Prospects Emerge for 2024 Key Takeaways: The healthcare industry experienced a significant transformation in 2023, driven by three defining trends: operational challenges due to staffing shortages and evolving payment models, looming patent cliffs for pharma manufacturers and a biotech funding slowdown that impacted

Healthcare (HC)
Forward Through Uncertainty: What Biopharma Leaders Are Saying About the FDA, R&D Investment
Insights
Forward Through Uncertainty: What Biopharma Leaders Are Saying About the FDA, R&D Investment 

Key Takeaways Recent FDA changes have generated uncertainty across the biopharma sector, with questions mounting around approval timelines, shifting trial expectations, and regulatory consistency. In May and June 2025, THL surveyed 100 biopharma decision-makers—spanning early-stage biotechs to top 50 pharma companies—to better understand how today’s regulatory and market dynamics are influencing R&D investment. Most respondents plan to maintain

Healthcare (HC)
From One to Twenty: How CSafe Became a Leader in the Pharma Cold Chain
Insights
From One to Twenty: How CSafe Became a Leader in the Pharma Cold Chain 

In the world of pharmaceutical logistics, maintaining the precise temperature of biologically based therapies like the Covid vaccine is mission critical. Even minor temperature fluctuations can compromise the efficacy of life-saving drugs. CSafe, a leading provider of cold chain shipping solutions, ensures that pharmaceutical products reach their destination without deviation from required temperature set points. Its

Healthcare (HC)
2023 Healthcare Trends and Our Outlook for 2024
Insights
2023 Healthcare Trends and Our Outlook for 2024 

Operational Challenges, Patent Cliffs & Biotech Funding Slowdown, and Generative AI Define 2023; Encouraging Prospects Emerge for 2024 Key Takeaways: The healthcare industry experienced a significant transformation in 2023, driven by three defining trends: operational challenges due to staffing shortages and evolving payment models, looming patent cliffs for pharma manufacturers and a biotech funding slowdown that impacted

Healthcare (HC)

No results were found

No results were found